Visualization of large-scale high dimensional data tool is highly valuable for scientific discovery in many fields. We present PubChemBrowse, a customized visualization tool for cheminformatics research. It provides a novel 3D data point browser that displays complex properties of massive data on commodity clients. As in GIS browsers for Earth and Environment data, chemical compounds with similar properties are nearby in the browser. PubChemBrowse is built around in-house high performance parallel MDS (Multi-Dimensional Scaling) and GTM (Generative Topographic Mapping) services and supports fast interaction with an external property database. These properties can be overlaid on 3D mapped compound space or queried for individual points. We prototype use with Chem2Bio2RDF system using SPARQL query language to access over 20 publicly accessible bioinformatics databases. We describe our design and implementation of the integrated PubChemBrowse application and outline its use in drug discovery. The same core technologies can be used to develop similar high dimensional browsers in other scientific areas.
INTRODUCTION
The scale of scientific data generated by new instruments or experiments along with substantial public accessibility make the issue of tools a challenging problem. Volumes of PubChem data need to be visualized towards the end of capture, curation, and analysis pipeline to support interactive studies. To browse 60 million intrinsically highdimensional NIH PubChem data, we have developed a 3D data point visualization tool, named PubChemBrowse, to display chemical structures with complex properties such as gene and disease relationships established through querying Chem2Bio2RDF system [1] for drug discovery.
We are applying parallel Multidimensional Scaling (MDS) and Generative Topographic Mapping (GTM) algorithms to structural descriptors of around 60 million chemical structures in the PubChem dataset, to provide three-dimensional graphical plot representations of the structural diversity of nearly all of the chemical compounds that are currently known. By labeling these plots with properties of the compound, including simple properties like molecular weight, and complex properties such as gene and disease relationships established through querying our Chem2Bio2RDF system, we can investigate the overall properties of regions of chemical space inhabited by PubChem compounds, as well as embedding new compounds into this framework.
In section 2, we give a brief overview of related work and our high performance parallel dimension reduction technologies including Multidimensional Scaling (MDS) and Generative Topographic Mapping (GTM) algorithms and relational biochemical repository framework -Chem2Bio2RDF and its SPARQL query interface. Section 3 presents details of our design and implementation of an integrated system PubChemBrowse that plots 3D PubChem compounds as well as embedding new compounds retrieved in real time with various labeling capabilities. A case study is given in section 4 with a data set of up to 930,000 data points followed by a summary of our work and future improvements.
DATA VISUALIZATION AND REMOTE DATA ACCESS
Large scale data visualization is an active research area in many fields of science: The Sloan Digital Sky Survey (SDSS) project [2] for astronomy, UCSC [3] and Ensemble [4] for genomics, and Google Earth for geology. Although designed with different technologies, they share one common concept: users need only a lightweight client but can access huge data that are curated and processed through intensive computation. We have used a multi-stage pipeline model to explore natural data parallelism for large-scale scientific problems. This has been demonstrated in our biology gene sequencing application from data acquisition, analysis, reduction and aggregation for visualization and implemented with both Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. To copy otherwise, to republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. classic HPC and Cloud technologies [5] . We are taking a similar approach for the cheminformatics research, assisting drug discovery from large dataset. It is also worth mentioning that [6] has introduced data visualization for drug discovery and a visualization tool. We present the same type of tool for drug discovery but we integrate our system with more cutting-edge technologies: high-performance visualization algorithms based on HPC and Cloud environments, large data access by using semantic web technologies, and a lightweight 3D visualization client.
In the field of drug discovery, which aims at mining causeand-effect relationships between genes and diseases from large volume of data sources, one needs to access various kinds of databases -such as PubChem for chemical compounds and structures, the Comparative Toxicogenomics Database (CTD) for gene information, the DrugBank database, to name a few -and visualize them in 2D or 3D space to explore findings and verify results.
More specifically, such process typically involves three main tasks: i) visualizing multi-dimensional PubChem data in 3D space, ii) finding relationships from various public databases, such as gene-compounds and/or disease-compounds, and assigning labels to chemical compounds, and iii) displaying labels by using different colors or symbols in the previous 3D visualization and exploring the results. The last two steps can be repeated until we have meaningful discovery by overlaying new information to the previous results.
Authors have been researching on developing high performance visualization algorithms, such as parallel MDS and GTM and their interpolation extensions [7, 8] , to visualize large PubChem dataset in 3D space by using our in-house 3D data point visualization tool and now we extend its functionality to access external data sources in a dynamic way.
An issue in dealing with various types of databases in drug discovery is that databases are often too big to store in local storage and hard to maintain consistency with the original dataset since their frequent updates. Another issue can arise due to non-uniform data structures. Typically those databases are not compatible to each other so that elaborated work needs to be done to use them together. To overcome such problems, Chem2Bio2RDF system has been developed to aggregate various public databases for chemical or biological information and provide an uniform interface which enables users to access the multiple databases by using SPARQL as a standard query language in semantic web technology. Our new tool, named PubChemBrowse, can interact with Chem2Bio2RDF system by using SPARQL query to access various databases and large number of datasets in an online and uniform way.
Data visualization algorithms
Among many dimension reduction algorithms, we focus on using Multidimensional Scaling (MDS) [9] and Generative Topographic Mapping (GTM) [10] due to their popularity and theoretical strength. More details are as follow.
MDS : Multidimensional scaling (MDS) is a general term of the techniques to configure low dimensional mappings of the given high-dimensional data with respect to the pairwise proximity information, while the pairwise Euclidean distance within the target dimension of each pair is approximated to the corresponding original proximity value. To solve MDS problem, we use SMACOF algorithm. For details of the SMACOF algorithm, please refer to [11] .
GTM : GTM is an unsupervised learning algorithm for modeling the probability density of data and finding a nonlinear mapping of high-dimensional data in a low-dimension space. GTM is also known as a principled alternative to SelfOrganizing Map (SOM) which does not have any density model, GTM defines an explicit probability density model based on Gaussian distribution [10] and seeks the best set of parameters associated with Gaussian mixtures by using Expectation-Maximization (EM) method.
MDS and GTM Interpolation : Both are an extension to the original MDS and GTM algorithm, designed to process much larger data points with sampling approaches. With minor trade-off of approximation, interpolation approach for MDS and GTM can visualize millions of data points with modest amount of computations and memory requirement. In [7] , up to 2 million PubChem data points has been visualized by using parallelized MDS and GTM interpolation algorithms.
Remote data access
Chem2Bio2RDF is an integrated repository of chemogenomic and systems chemical biology data by aggregating over 20 publicly accessible datasets in Resource Description Framework (RDF) format and enable users to access them by using SPARQL which is a standard query language for RDF data and is a part of semantic web technology.
We can take an advantage of Chem2Bio2RDF system for accessing multiple data sources in an online manner by sending SPARQL query and parsing results in RDF format. In this way, users can visualize data with more information-rich context by mashing up with other data sources with ease.
THE PUBCHEMBROWSE SYSTEM
We have developed PubChemBrowse tool to visualize 3D data as an output of high-performance visualization algorithms as well as interact with external data sources via Chem2Bio2RDF system to provide rich and on-line information by utilizing semantic web interfaces. Fig. 1 illustrates our PubChemBrowse architecture. It consists of mainly 3 components: i) high-performance visualization algorithms, such as parallel MDS and GTM, which generate 3D maps for large and high-dimensional data by utilizing parallel clustering infrastructure [7, 8] , ii) an userfriendly 3D browsing interface to rotate, pan, and zoom in-/out data space and display annotations or meta-data, and iii) SPARQL query interface to access the remote data repository Chem2Bio2RDF for updating and adding new data points in an on-line manner. More details of each component are as follow.
High-performance visualization algorithms : Currently PubChemBrowse can visualize the outputs from our in-house parallel implementations of 4 main dimension reduction algorithms: MDS, GTM, MDS interpolation, and GTM interpolation. All of them can run in high-throughput clustering infrastructure by maximally utilizing multi-core environments. Mostly those algorithms run in a batch mode but interpolation algorithms can run in an online mode too. 3D data browser : As shown in Fig. 2a and Fig. 2b , one can visualize 3D data points and browse them in various ways: rotating, zooming, and viewing meta-data including chemical structures available from PubChem database.
SPARQL query : As shown in Fig. 2c , our system has an interface for users to compose SPARQL query and send to Chem2Bio2RDF system remotely by using REST protocol, which is a standard web service protocol. Then, the Chem2Bio2RDF system will fetch the query and return back results in XML format. Our system can parse the XML information and update or mash up the results in user's working plot.
APPLICATION STUDY
We have been used our PubChemBrowse in various cheminformatics researches aiming at exploring and discovering complicated compound-gene-disease relationships from large sets of data. In the following we will show a few examples of our results.
CTD data for gene-disease :
In Fig. 3 , we have visualized about 930,000 gene-related chemical compounds having 166 dimensions in PubChem database by using both MDS and GTM algorithms and labeled as different colors to display cause-and-effect associations between genes and diseases based on Comparative Toxicogenomics Database (CTD) dataset so that distances between points represent structural similarity and colors of points are labels based on CTD data.
By using our PubChemBrowse, one can easily identify points of interest by colors or select a group of points distinguished by structural distribution in 3D space. One can also easily browse the data by rotating, zooming, or panning the 3D space to search for more details. Also, updating the labels of points or adding new ones in the figure can be easily done by sending on-line SPARQL query to Chem2Bio2RDF system. With our tool, researchers can easily browse very large set of data with ease.
Chem2Bio2RDF : In Fig. 4 , we have visualized 234,000 chemical compounds which may be related with a set of 5 genes of interest (ABCB1, CHRNB2, DRD2, ESR1, and F2) based on the dataset collected from major journal literatures which is also stored in Chem2Bio2RDF system. The purpose of this research is to find chemical compounds related with genes reported in scientific literatures and verify their relationships through visualization.
As such, researchers need to gather information from dif- ferent data sources and overlay them in one figure. Our system can help this repetitive procedure by supporting online multiple data access through SPARQL queries. Solvent screening : In Fig. 5 , we have visualized 215 solvents used in a pharmaceutical pre-screening process [12] along with 100 thousand chemical compounds. The result shows that our tool can clearly separate solvents from other chemicals based on the structural characteristics and users can navigate the large chemical space with visualization.
CONCLUSION
In this paper we discuss our design and implementation of PubChemBrowse, an integrated 3D data point visualization tool customized for browsing massive cheminformatics data. Our system is generated by our in-house highperformance visualization algorithms and interact with external Chem2Bio2RDF system by using SPARQL query language to access publicly accessible multiple bioinformatics databases. Further, we can embed new points and label various bioinformatics related datasets to assist on-going research results from data mining projects for drug-discovery.
As for the future work, we will integrate clustering service into our system to display entire compounds as a hierarchical structure so that users can easily zoom in and zoom out on a region with different levels of details. We will also continue to develop our system to integrate with more external systems transparently via semantic web interfaces.
